Abstract
Hybridoma-secreted monoclonal anti-colorectal carcinoma antibodies 19-9, 52a, and C4 14 bind specifically to cells of colorectal, gastric, and pancreatic carcinoma in tissue culture. The assay for the detection of antigen in human sera is based on the inhibition of binding of monoclonal antibodies to target preparations of colorectal carcinoma cells. Binding of monoclonal antibody 52a was inhibited more than 12% by 163 of 255 sera from patients from various stages of carcinoma of colon and rectum, by 45 of 49 sera from patients with pancreatic carcinoma, and by 8 of 11 sera from patients with gastric carcinoma. By contrast, only 7 of 89 sera from patients with other malignancies and 2 of 108 sera from healthy donors inhibited binding of this monoclonal antibody by more than 12%. These studies show the potential usefulness of monoclonal antibodies in the diagnosis of human malignancy.
Similar content being viewed by others
References
Herlyn M, Steplewski Z, Herlyn D, Koprowski H: Colorectal carcinoma-specific antigen: Detection by means of monoclonal antibodies. Proc Natl Acad Sci USA 76:1438–1442, 1979
Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5:957–972, 1979
Steplewski Z, Chang TH, Herlyn M, Koprowski H: Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells. Cancer Res 41:2723–2727, 1981
Magnani JL, Brockhaus M, Smith DF, Ginsburg V, Blaszczyk M, Mitchell KF, Steplewski Z, Koprowski H: A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma. Science 212:55–56, 1981
Chang TH, Steplewski Z, Koprowski H: Production of monoclonal antibodies in serum-free medium. J Immunol Methods 39:369–375, 1980
Koprowski H, Herlyn M, Steplewski Z, Sears HF: Specific antigen in serum of patients with colon carcinoma. Science 212:53–55, 1981
Chang TH, Steplewski Z, Sears HF, Koprowski H: Detection of monoclonal antibody-defined colorectal carcinoma antigen by solid-phase binding inhibition radioimmunoassay. Hybridoma 1:37–45, 1981
Sears HF, Herlyn M, del Villano B, Steplewski Z, Koprowski H: Monoclonal antibody detection of a circulating tumor-associated antigen. II. A longitudinal evaluation of patients with colorectal cancer. J Clin Immunol 2:141–149, 1982
Guirgis HA, Lynch HT, Harris RE, Vandevoorde JP: Carcinoembryonic antigen (CEA) in the cancer family syndrome. Cancer 42:1574–1578, 1978
Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PP, Schwarts M: Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer 47:2364–2367, 1981
Atkinson BF, Ernst CS, Herlyn M, Sears HF, Steplewski Z, Koprowski H: Immunoperoxidase localization of a monoclonal antibody-defined gastrointestinal monosialoganglioside (manuscript in preparation)
Conference Report. Carcinoembryonic antigen: Its role as a marker in the management of cancer. National Institutes of Health consensus development conference statement. Cancer Res 41:2017–2018, 1981
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Herlyn, M., Sears, H.F., Steplewski, Z. et al. Monoclonal antibody detection of a circulating tumor-associated antigen. I. Presence of antigen in sera of patients with colorectal, gastric, and pancreatic carcinoma. J Clin Immunol 2, 135–140 (1982). https://doi.org/10.1007/BF00916897
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00916897